Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 7/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901585 | 0.88 | CYP3A4 (0.67) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL29220387 | 0.88 | CYP3A4 (0.67) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| Propene SCHEMBL17797847 | 0.87 | TSHR (0.56) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL17797782 | 0.84 | TSHR (0.66) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL8238432 | 0.83 | CYP3A4 (0.77) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL15946442 | 0.83 | THRB (0.54) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL29220389 | 0.82 | CYP3A4 (0.59) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL2908713 | 0.81 | ALDH1A1 (0.55) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL14984028 | 0.81 | TSHR (0.68) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL29860709 | 0.81 | TSHR (0.65) | CYP3A4ALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | SOOCHOW UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | AOC1, AOC2, AOC3 | CYP3A4 103/4885ALDH1A1 31/4885TSHR 4420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.